Chief Physician, Associate Professor, Member of the Party Committee of Peking University Cancer Hospital, and concurrently Deputy Director of the Medical Affairs Department. Specialties: Comprehensive surgical treatment of gastrointestinal tumors, including radical minimally‑invasive surgery, hyperthermic intraperitoneal chemotherapy, perioperative chemotherapy, targeted therapy and immunotherapy. Graduated from Peking University Health Science Center in 2004 with a Doctorate in Oncology. In 2009, he worked as a foreign specialist physician at the Faculty of Medicine, University of Strasbourg in France, obtained the specialist physician degree from the Faculty of Medicine, University of Strasbourg, and was awarded the certificate of completion for the advanced course in laparoscopic surgery for gastrointestinal tumors at the European Institute for Telesurgery (IRCAD). He has participated in clinical research projects on comprehensive gastric cancer treatment under the National Eleventh‑Five‑Year Science and Technology Support Program, the research project on the establishment and sharing of a national multi‑center clinical specimen resource bank for malignant tumors supported by the Ministry of Science and Technology, as well as the translational medicine and comprehensive prevention‑treatment research for malignant tumors — translational medicine and comprehensive prevention‑treatment research for gastric cancer. He has published numerous papers in professional journals and participated in compiling *Biobank Capacity Building and Best Practices*. He holds one national patent (Invention Title: Mass Spectrometry Identification Method for Nucleophosmin Alternative Spliceosomes and Gastric Cancer Diagnostic Kit, Patent No.: ZL 2011 1 0006721.X). He received the Second Prize of the 2012 Huaxia Medical Science and Technology Award and the Third Prize of the 2012 Beijing Municipal Science and Technology Progress Award.